256 related articles for article (PubMed ID: 29222829)
81. Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
Petrella TM; Robert C; Richtig E; Miller WH; Masucci GV; Walpole E; Lebbe C; Steven N; Middleton MR; Hille D; Zhou W; Ibrahim N; Cebon J
Eur J Cancer; 2017 Nov; 86():115-124. PubMed ID: 28987768
[TBL] [Abstract][Full Text] [Related]
82. Hypertrophic lichen planus-like eruption following pembrolizumab.
Chapman S; Ashack K; Dapprich DC
Cutis; 2021 Jan; 107(1):E10-E11. PubMed ID: 33651868
[No Abstract] [Full Text] [Related]
83. Pembrolizumab-associated ocular myasthenia gravis.
Liu Q; Ayyappan S; Broad A; Narita A
Clin Exp Ophthalmol; 2019 Aug; 47(6):796-798. PubMed ID: 30859689
[No Abstract] [Full Text] [Related]
84. Pembrolizumab (Keytruda°) and metastatic or inoperable melanoma.
Prescrire Int; 2017 May; 26(182):118-119. PubMed ID: 30730667
[No Abstract] [Full Text] [Related]
85. Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
Amber KT; Valdebran M; Lu Y; De Feraudy S; Linden KG
J Dtsch Dermatol Ges; 2018 Feb; 16(2):196-198. PubMed ID: 29389067
[No Abstract] [Full Text] [Related]
86. CMV disease and colitis in a kidney transplanted patient under pembrolizumab.
Gueguen J; Bailly E; Machet L; Miquelestorena-Standley E; Stefic K; Gatault P; Büchler M
Eur J Cancer; 2019 Mar; 109():172-174. PubMed ID: 30731278
[No Abstract] [Full Text] [Related]
87. Case of lichen planus pemphigoides after pembrolizumab therapy for advanced urothelial carcinoma.
Okada H; Kamiya K; Murata S; Sugihara T; Sato A; Maekawa T; Komine M; Ohtsuki M
J Dermatol; 2020 Sep; 47(9):e321-e322. PubMed ID: 32515025
[No Abstract] [Full Text] [Related]
88. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.
Berger M; Amini-Adlé M; Crumbach L; Paubelle E; Dalle S
Eur J Cancer; 2019 May; 112():94-97. PubMed ID: 30954716
[No Abstract] [Full Text] [Related]
89. Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma.
Adler NR; Murray WK; Brady B; McCormack C; Pan Y
Clin Exp Dermatol; 2018 Jun; 43(4):497-499. PubMed ID: 29396853
[No Abstract] [Full Text] [Related]
90. Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.
Jespersen H; Bjursten S; Ny L; Levin M
Lancet Oncol; 2018 Jun; 19(6):e327. PubMed ID: 29893264
[No Abstract] [Full Text] [Related]
91. Lichen planus of the external urinary meatus masquerading sexually transmitted disease.
Verma P; Pandhi D
Int J STD AIDS; 2012 Jan; 23(1):73-4. PubMed ID: 22362699
[TBL] [Abstract][Full Text] [Related]
92. Development of lichen planus following benralizumab treatment.
Morimoto H; Fukuchi K; Ogura Y; Ohtsuka M; Tokura Y
Eur J Dermatol; 2021 Apr; 31(2):261-262. PubMed ID: 33814362
[No Abstract] [Full Text] [Related]
93. Lichen planus: an unusual cause of oesophageal stricture.
Bachmeyer C; Benchaa B; Rohaut B; Petitjean B; Danne O; Blum L
J Eur Acad Dermatol Venereol; 2007 May; 21(5):719-21. PubMed ID: 17448014
[No Abstract] [Full Text] [Related]
94. Checkpoint inhibitors in the emergency department.
Bachmeier CA; Morton A
Emerg Med Australas; 2019 Apr; 31(2):288-289. PubMed ID: 30690867
[No Abstract] [Full Text] [Related]
95. Mitochondrial myopathy associated with anti-programmed cell death 1 therapy.
Ibrahim T; Adam C; Routier E; Slama A; Robert C
Eur J Cancer; 2019 Mar; 110():71-73. PubMed ID: 30772655
[No Abstract] [Full Text] [Related]
96. Resolution of pembrolizumab-associated lichenoid dermatitis with a single dose of methotrexate.
Varma A; Friedlander P; De Moll EH; Desman G; Levitt J
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621697
[TBL] [Abstract][Full Text] [Related]
97. Lichen Planus Pemphigoides Induced by Camrelizumab in Combination With Lenvatinib.
Zhang X; Wang J; Wang H; Qin X; Zhang R
Am J Dermatopathol; 2024 May; 46(5):332-333. PubMed ID: 38457682
[No Abstract] [Full Text] [Related]
98. Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis.
Algaeed M; Mukharesh L; Heinzelmann M; Kaminski HJ
Neurology; 2018 Oct; 91(14):e1365-e1367. PubMed ID: 30275130
[No Abstract] [Full Text] [Related]
99. Lichen planus pemphigoides after pembrolizumab immunotherapy in an older man.
Ee S; Liang MW; Tee SI; Wang DY
Ann Acad Med Singap; 2022 Dec; 51(12):804-806. PubMed ID: 36592152
[No Abstract] [Full Text] [Related]
100. [Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome].
Demirtas S; El Aridi L; Acquitter M; Fleuret C; Plantin P
Ann Dermatol Venereol; 2017 Jan; 144(1):65-66. PubMed ID: 28011090
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
